granted
on 31 May 2024
Last Applicant/ Owned by
400 Interpace Parkway
Parsippany
NJ
07054
Serial Number
97705134 filed on 06th Dec 2022
Registration Number
N/A
Correspondent Address
Laurence Rickles TEVA PHARMACEUTICALS USA, INC.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous Read More
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations
11th 000101
11th 000101
No 97705134
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
31st May 2024 | SOU EXTENSION 1 FILED |
31st May 2024 | SOU EXTENSION 1 GRANTED |
31st May 2024 | SOU TEAS EXTENSION RECEIVED |
19th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
24th Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
24th Oct 2023 | PUBLISHED FOR OPPOSITION |
04th Oct 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
18th Sep 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
18th Sep 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
18th Sep 2023 | EXAMINERS AMENDMENT E-MAILED |